IDF-IMNE webinar on implementation of once-weekly basal insulins

On 20 January 2025, the International Diabetes Federation (IDF) and the Institute for Medical and Nursing Education (IMNE) are co-organising the webinar, “It’s about timing and targeting: Practical guidance on implementation of once-weekly basal insulins,” targeted at endocrinologists, diabetologists and family medicine specialists.

While non-insulin therapies exist, many people living with diabetes will still need insulin therapy as type 2 diabetes (T2D) progresses.

This webinar covers:

Guideline-based insulin initiation and titration.
Current basal insulin benefits and limitations.
Barriers to insulin therapy.
Breakthrough findings on once-weekly basal insulins and their clinical impact.

Date and Time:

20 January 2025

09:30 – North America (Mexico City)
12:30 – South America (Brasília, Buenos Aires)
16:30 – Europe (Copenhagen, Berlin, Madrid)
19:30 – Middle East (Dubai, Riyadh)
21:00 – South Asia (Mumbai, Delhi, Colombo)

Registration

This webinar is open to health professionals globally, except for those based in the U.K. and the U.S.A.

Learning outcomes

Upon completion of this programme, the learner will be able to:

Explain the adverse consequences of therapeutic inertia and related influence on patient outcomes, with a specific focus on the implications of delaying basal insulin therapy.
Propose strategies to address barriers to the acceptance of insulin therapy among individuals with type 2 diabetes.
Discuss data for once-weekly basal insulins and related potential impact on the management of people with type 2 diabetes.
Develop and implement individualised basal insulin plans, including once-weekly basal insulins were appropriate, incorporating initiation, dosing, titration/intensification, and special circumstances.

Scientific Committee:

Prof. Tina Vilsbøll, Prof. Roopa Mehta

Speakers

Programme

Welcome, pre-test and introduction (10 mins) Prof. Tina Vilsbøll
Is the current treatment paradigm improving outcomes for people with T2D? The role of basal insulin in modern T2D management (7 mins) Prof. Tina Vilsbøll
Why is insulin uptake so low? Overcoming patient and physician barriers to insulin use (10 mins) Dr. Hamed Farooqi
The emerging role of once-weekly insulins: How might these agents change the basal insulin landscape? (12 mins) Prof. Tina Vilsbøll
Insights for the clinic: Practical guidance on effective use of basal insulin therapy (15 mins) Prof. Roopa Mehta
Panel discussion and interactive question and answer session (15 mins) All
Post-test and conclusions (6 mins) Prof. Tina Vilsbøll

CME Accreditation

This webinar has been granted 1.0 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).

If you have any questions about the webinar, please contact [email protected]

Provided by the Institute of Medical and Nursing Education
Supported by an educational grant from Novo Nordisk A/S